Resalis Therapeutics

Resalis Therapeutics is a biopharma company developing oligonucleotide antisense therapies for metabolic disorders like NAFLD, MAFLD, NASH, obesity, and cancer, with a lead candidate, RES 010, targeting key pathways in obesity and fatty liver disease.Resalis Therapeutics is a biopharma company developing oligonucleotide antisense therapies for metabolic disorders like NAFLD, MAFLD, NASH, obesity, and cancer, with a lead candidate, RES 010, targeting key pathways in obesity and fatty liver disease.